Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt.

Saved in:
Bibliographic Details
Title: Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt.
Authors: Cao W; The Hormel Institute, University of Minnesota, Austin, MN 55912, USA., Shen R; The Hormel Institute, University of Minnesota, Austin, MN 55912, USA., Richard S; The Hormel Institute, University of Minnesota, Austin, MN 55912, USA., Liu Y; Sir Run Run Shaw Hospital, Nanjing Medical University, Nanjing, Jiangsu 211166, P.R. China., Jalalirad M; Mayo Clinic, Rochester, MN 55905, USA., Cleary MP; The Hormel Institute, University of Minnesota, Austin, MN 55912, USA., D'Assoro AB; Mayo Clinic, Rochester, MN 55905, USA., Gradilone SA; The Hormel Institute, University of Minnesota, Austin, MN 55912, USA., Yang DQ; The Hormel Institute, University of Minnesota, Austin, MN 55912, USA.
Source: Oncology reports [Oncol Rep] 2022 Feb; Vol. 47 (2). Date of Electronic Publication: 2021 Dec 27.
Publication Type: Journal Article
Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1791-2431
DOI:10.3892/or.2021.8252